Similar Stories to Astrazeneca's Q1 Profit Falls 11% Despite Strong Diabetes Drug Growth on Bing News

Diabetes drug growth helps spur AstraZeneca's top line modestly higher, however higher costs and patent expirations take their toll.

Topics:  astrazeneca   diabetes drug growth   higher   
BING NEWS:
  • Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Flashes A Sell Signal
    Tandem Diabetes stock rocketed Friday after the insulin pump-maker topped first quarter expectations. But DaVita stock reversed lower.
    05/3/2024 - 9:06 am | View Link
  • Obesity drugmaker Novo Nordisk’s Q1 profit beats forecast
    Novo Nordisk posted on Thursday first-quarter operating profit above analyst forecasts, as the Danish drugmaker races to boost output of its hugely popular weight-loss drug Wegovy and fend off ...
    05/1/2024 - 7:11 pm | View Link
  • Eli Lilly raises financial guidance thanks to robust diabetes sales in Q1
    As a result of its strong topline performance, Eli Lilly raised its full year revenue guidance by $2 billion to the range of $42.4 billion to $43.6 billion.
    04/30/2024 - 5:01 am | View Link
  • Barclays Q1 profit falls 12% as trading slump hits
    Barclays reported a slightly smaller than expected 12% fall in first quarter profit on Thursday, boosting confidence among investors that its turnaround task was on track despite lower income from ...
    04/24/2024 - 8:20 pm | View Link
  • Artisan Global Equity Fund Q1 2024 Commentary
    Artisan Global Equity Fund's portfolio solidly outperformed the MSCI AC World Index. Click here to read the full fund letter.
    04/24/2024 - 2:30 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News